Document is current
Any future updates will be listed below
-
Authors
Jensen, S. https://orcid.org/0000-0001-8662-0515
Tvedskov, T. F.
Bechmann, T.
Tramm, T.
Jensen, M.-B.
Rahr, H. B.
Lautrup, M. D.
-
Funding
Funding for this research was provided by:
Region Syddanmark
Direktør Kurt Bønnelycke og Hustru fru Grethe Bønnelyckes Fond
Else og Mogens Wedell Wedellsborgs Fond
Grosserer A.V. Lykfeldt og Hustrus Legat
Syddansk Universitet
University of Southern Denmark
- License Information
-
More Information
Article History
Received: 13 May 2025
Accepted: 22 July 2025
First Online: 20 August 2025
Disclosure
: M.-B. Jensen reports financial interests as a member of an advisory board for Novartis. T. Bechmann reports financial interests as a member of an advisory board for AstraZeneca. T. Tramm reports financial interests as a member of an advisory board for AstraZeneca and has received honoraria for lectures from Pfizer. All interests are unrelated to the submitted work. The remaining authors have no conflicts of interest.
: The processing of personal data was reported to and approved by the Region of Southern Denmark and listed in the internal record (21/54354 and 21/50412) cf. Art 30 of The EU General Data Protection Regulation. According to Danish law, ethical approval from the Ethical Committee is not required for this type of register-based study.
